C3.ai Inc vs Enveric Biosciences Inc — how do they compare? C3.ai Inc trades at $10.54 (market cap $1.65B), while Enveric Biosciences Inc trades at $1.45 (market cap $6.20M). The key difference: C3.ai Inc is far larger — about 266.1× Enveric Biosciences Inc's market cap, and C3.ai Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| AI | ENVB | |
|---|---|---|
Market Cap | $1.65B | $6.20M |
Sector | Technology | Health |
52-Week High | $19.66 | $17.40 |
52-Week Low | $7.76 | $1.27 |
Enterprise Value | $1.08B | $1.30M |
Trailing returns across standard periods
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Read more on AI →Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →